Skip to main content
. Author manuscript; available in PMC: 2019 Mar 15.
Published in final edited form as: J Neuroimmunol. 2017 Dec 29;316:74–79. doi: 10.1016/j.jneuroim.2017.12.014

Fig. 1.

Fig. 1

Evaluation of CXCL9 and IL-6 in sera from normal individuals (Control, N = 18), and in treated (N = 11) and untreated (N = 7) AIR Patients. Error bars represent the standard error of the mean. Top-Fig. A: Mean CXCL9 Levels. Statistical Analysis (Wilcoxon rank sum): Untreated Patients vs Normal individuals (p < 0.0009); Treated Patients vs Normal individuals (p < 0.0002); All AIR Patients vs Normal individuals (p < 0.00001). Bottom-Fig. B: Mean IL-6 levels. Statistical Analysis (Wilcoxon rank sum): Untreated Patients vs Normal Individuals (p < 0.0025); Treated Patients vs Normal individuals (p < 0.82); All AIR Patients vs Normal individuals (p < 0.082).